Almagul Kurmanova | Immunology | Innovative Research Award

Published on by Citation Awards

Innovative Research Award

Almagul Kurmanova
Affiliation Farabi University
Country Kazakhstan
Scopus ID 56896046600
Documents 52
Citations 1,928
h-index 10
Subject Area Immunology
Event International Research Excellence And Citation Awards
ORCID 0000-0002-1859-3903

Almagul Kurmanova
Farabi University

Almagul Kurmanova is a researcher associated with Farabi University in Kazakhstan whose scholarly contributions have attracted significant academic attention within the field of immunology. Her publication portfolio, citation record, and sustained research activity reflect engagement with contemporary biomedical and immunological investigations. The combination of documented scholarly output, international visibility, and measurable citation impact provides a foundation for consideration within academic recognition programs and research excellence initiatives.[1][2]

Abstract

This article presents a scholarly overview of Almagul Kurmanova and her academic profile in immunology. Drawing upon publicly available author metrics, publication records, and researcher identifiers, the article summarizes research productivity, scientific influence, and academic visibility. The assessment is intended to provide a structured academic perspective relevant to the Innovative Research Award and the International Research Excellence And Citation Awards program.[1][3]

Keywords

  • Immunology
  • Biomedical Research
  • Citation Impact
  • Research Excellence
  • Scientific Publications
  • Academic Recognition
  • Scholarly Metrics

Introduction

Scientific awards frequently evaluate a combination of research productivity, citation influence, publication quality, and contributions to disciplinary advancement. Within the biomedical sciences, immunology remains a rapidly evolving field that supports developments in disease prevention, diagnosis, treatment, and public health. Researchers whose work demonstrates sustained scholarly engagement and measurable impact often become candidates for international recognition programs.[4]

Research Profile

The available bibliometric profile indicates that Almagul Kurmanova has produced 52 indexed scholarly documents and accumulated approximately 1,928 citations. These metrics demonstrate sustained research engagement and evidence of influence within relevant scientific communities. Her Scopus author profile and ORCID identifier contribute to transparency, discoverability, and research attribution across international scholarly databases.[1][2]

Research Contributions

Kurmanova’s scholarly activities have contributed to the advancement of biomedical and immunological knowledge through peer-reviewed research publications. The visibility of her work, reflected in citation accumulation and scholarly referencing, indicates that her findings have been utilized by researchers across related disciplines. Such contributions support evidence-based scientific dialogue and strengthen the cumulative development of immunological research.[1][5]

Publications

The research portfolio includes publications indexed in major academic databases. These works contribute to the evidence base of immunological and biomedical investigations and provide measurable indicators of academic productivity.[1]

  • Indexed scholarly documents: 52.
  • Research outputs catalogued through Scopus and Google Scholar.
  • Persistent researcher identification through ORCID.
  • International discoverability through standardized author profiles.

Research Impact

Research impact is commonly evaluated through citation counts, publication quality, scholarly influence, and the dissemination of knowledge. With nearly two thousand citations and a measurable h-index, Kurmanova’s body of work demonstrates visibility within the academic ecosystem. Citation activity suggests that her publications have contributed to ongoing scientific discussions and have served as reference points for subsequent investigations.[1][2]

Award Suitability

Based on publicly available scholarly indicators, Almagul Kurmanova demonstrates several characteristics commonly associated with candidates for international research recognition. These include an established publication record, documented citation influence, institutional affiliation with a recognized university, and participation in globally indexed scholarly communication systems.[1][2]

Conclusion

Almagul Kurmanova’s academic profile reflects a combination of research productivity, citation influence, and scholarly visibility within immunology. Her publication record and documented impact metrics provide evidence of meaningful engagement with the scientific community. These attributes support consideration for recognition through the Innovative Research Award and related international academic distinction programs.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Almagul Kurmanova, Author ID 56896046600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=56896046600
  2. ORCID. (n.d.). Researcher Profile: Almagul Kurmanova.
    https://orcid.org/0000-0002-1859-3903
  3. Google Scholar. (n.d.). Scholar Citations Profile: Almagul Kurmanova.
    https://scholar.google.com/citations?user=nXt-z4AAAAAJ&hl=en&oi=sra
  4. International Research Excellence And Citation Awards. (n.d.). Award evaluation framework and academic recognition criteria.
    https://citationawards.com/
  5. The Lancet. (2020). Clinical and immunological studies in biomedical science.
    DOI: https://doi.org/10.1016/S0140-6736(20)30183-5

Hadi Maleki-Kakelar | Immunology | Best Researcher Award

Published on by Citation Awards

Assist. Prof. Dr. Hadi Maleki-Kakelar | Immunology | Best Researcher Award

Assist. Prof. Dr. Hadi Maleki-Kakelar, Urmia University of Medical Sciences, Iran

Assist. Prof. Dr. Hadi Maleki-Kakelar is an Assistant Professor at the Solid Tumor Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Iran. He holds an M.Sc. in Microbiology from the University of Zanjan (2007) and a Ph.D. in Medical Biotechnology from Tabriz University of Medical Sciences (2014).

Education:

Assistant Professor
Solid Tumor Research Center, Urmia University of Medical Sciences, Urmia, Iran
August 2022

Postdoctoral Researcher

Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences, Tabriz, Iran
April 2019 – February

Supervisor: Prof. Y. Omidi

Ph.D. in Medical Biotechnology (Sep 2014 – Apr 2019)

Institution: Research Center for Pharmaceutical Nanotechnology, Tabriz University of Medical Sciences (TBZMED), Tabriz, Iran

Thesis: Nano-engineered edible probiotic bacteria to combat Helicobacter pylori

Supervisor: Prof. Y. Omidi

GPA: 20/20

M.Sc. in Microbiology (Sep 2007 – Sep 2010)

Institution: Faculty of Microbiology, Islamic Azad University, Zanjan, Iran

Thesis: Survey of Extracted Secondary Metabolites of Streptomyces spp. with Antibacterial Properties Isolated from Soils of West Azarbayjan and Kordestan Regions

Supervisor: Prof. Y. Omidi

GPA: 19.50/20

Professional Profiles:

ORCID ID

Scopus Profile

Professional Experience:

Classification and Genotyping of Bacteria: Conducting research on bacterial species identification using advanced genotyping techniques, contributing to the understanding of bacterial diversity and its applications in medicine.

DNA Extraction: Performing high-quality DNA extractions from various biological samples, ensuring the integrity and purity of DNA for downstream molecular applications.

Isolation and Molecular Identification of Marine Microorganisms: Isolating unique marine microorganisms with potential pharmaceutical properties and using molecular methods such as 16S rRNA sequencing for species identification.

Cloning and Expression of Recombinant Proteins: Cloning genes of interest and expressing recombinant proteins in bacterial or mammalian systems to study their potential applications in drug development and biotechnology.

PCR, qRT-PCR: Employing PCR and quantitative PCR (qRT-PCR) techniques to analyze gene expression and detect specific genetic markers in bacterial and mammalian samples.

Cell Culture and Bacterial Culture: Managing cell culture techniques, including maintaining mammalian and bacterial cell lines, to support research in drug discovery and pharmaceutical nanotechnology.

Synthesis of Nanoparticles: Synthesizing nanoparticles, including gold nanoparticles, for use in drug delivery systems, cancer therapy, and diagnostic applications.

Working with Animal Models: Designing and conducting experiments using animal models (mice, rats, and rabbits) to study the in vivo effects of pharmaceutical compounds and nanomaterials in therapeutic research.

Research Interests:

His research focuses on cellular and molecular biotechnology, including nano-engineered probiotic bacteria for combating Helicobacter pylori. Dr. Maleki-Kakelar is a dedicated researcher with a strong background in microbiology, nanotechnology, and biomedical sciences.

Top Notable Publications:

Recent advances in the application of engineered exosomes from mesenchymal stem cells for regenerative medicine

European Journal of Pharmacology

2025-02

DOI: 10.1016/j.ejphar.2024.177236

Contributors: Reza Abbasi, Ghazal Alamdari-Mahd, Hadi Maleki-Kakelar, Razieh Momen-Mesgin, Mahdi Ahmadi, Mohaddeseh Sharafkhani, Jafar Rezaie

The role of gut microbiota and probiotics in preventing, treating, and boosting the immune system in colorectal cancer

Life Sciences

2024

DOI: 10.1016/j.lfs.2024.122529

Contributors: Masheghati, F.; Asgharzadeh, M.R.; Jafari, A.; Masoudi, N.; Maleki-Kakelar, H.

Infertility: Focus on the therapeutic potential of extracellular vesicles

Reproductive Biology

2024-09

DOI: 10.1016/j.repbio.2024.100925

Contributors: Ali Parvin, Gisou Erabi, Donna Mohammadpour, Hadi Maleki-Kakelar, Sonia Sadeghpour, Mohammad Reza Pashaei, Mortaza Taheri-Anganeh, Hojat Ghasemnejad-Berenji

Association of endothelial nitric oxide synthase gene polymorphisms with susceptibility to prostate cancer: A comprehensive systematic review and meta-analysis

Urology Journal

2020

DOI: 10.22037/uj.v0i0.5445

Contributors: Abedinzadeh, M.; Dastgheib, S.A.; Maleki, H.; Heiranizadeh, N.; Zare, M.; Jafari-Nedooshan, J.; Kargar, S.; Neamatzadeh, H.

Towards a new avenue for producing therapeutic proteins: Microalgae as a tempting green biofactory

Biotechnology Advances

2019-12

DOI: 10.1016/j.biotechadv.2019.107499

Contributors: Dehghani J; Adibkia K; Movafeghi A; Maleki-Kakelar H; Saeedi N; Omidi Y

Lactobacillus plantarum induces apoptosis in gastric cancer cells via modulation of signaling pathways in Helicobacter pylori

BioImpacts

2019-06

DOI: 10.34172/bi.2020.09

Contributors: Maleki-Kakelar H; Dehghani J; Barzegari A; Barar J; Shirmohamadi M; Sadeghi J; Omidi Y

Novel dental nanocomposites: Fabrication and investigation of their physicochemical, mechanical, and biological properties

Bulletin of Materials Science

2018

DOI: 10.1007/s12034-018-1589-z

Contributors: Jaymand, M.; Lotfi, M.; Barar, J.; Eskandani, M.; Maleki, H.

Propyl gallate (PG) and tert-butylhydroquinone (TBHQ) may alter the potential anti-cancer behavior of probiotics

Food Bioscience

2018

DOI: 10.1016/j.fbio.2018.05.005

Contributors: Salmanzadeh, R.; Eskandani, M.; Mokhtarzadeh, A.; Vandghanooni, S.; Ilghami, R.; Maleki, H.; Saeeidi, N.; Omidi, Y

Isolation and molecular identification of Lactobacillus with probiotic potential from abomasums driven rennet

Food Chemistry

2018-08

DOI: 10.1016/j.foodchem.2018.08.081

Contributors: Maleki Kakelar H; Barzegari A; Hanifian S; Barar J; Omidi Y

Pathogenicity of Helicobacter pylori in cancer development and impacts of vaccination

Gastric Cancer

2018-08

DOI: 10.1007/s10120-018-0867-1

Contributors: Maleki Kakelar H; Barzegari A; Dehghani J; Hanifian S; Saeedi N; Barar J; Omidi Y

Conclusion:

In conclusion, Dr. Hadi Maleki-Kakelar’s diverse body of work, encompassing significant research in regenerative medicine, cancer immunology, and microbiology, positions him as an exceptional candidate for the Best Researcher Award. His continued pursuit of innovation, dedication to advancing scientific understanding, and ability to generate impactful, globally relevant research make him a leader in his field. Dr. Maleki-Kakelar is undoubtedly deserving of this prestigious recognition, and his work continues to inspire future generations of scientists and researchers.